Robert Hettle
3PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 13, 2023
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden.Maria Polyzoi, Mattias Ekman, Anja Reithmeier
|Sep 08, 2023
Real-world outcomes for first line next-generation hormonal agents in metastatic prostate cancer: a systematic review.Robert Hettle, Adela Mihai, Shona H Lang
|Feb 09, 2021
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with <i>BRCA</i>-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore.David Sp Tan, Jack Junjie Chan, Robert Hettle
Pageof 1
Frequent Collaborators
1 joint publications
David Sp Tan
1 joint publications
Jack Junjie Chan
1 joint publications
Wrik Ghosh
1 joint publications
Amrita Viswambaram
1 joint publications
Cindy Chen Yu
1 joint publications
Adela Mihai
1 joint publications
Shona H Lang
1 joint publications
Sophie Tatman
1 joint publications
Stephanie L Swift
